Register entry

PTC Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
8
Labeller names
2
Live patents
8
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

8

8 active NDC listings: 8 human prescription drug. By marketing category: NDA 7, BLA 1.

Dosage formNDCs
tablet4
powder2
suspension2
RouteNDCs
oral7
intracerebral1
Labeller name on the listingNDCs
ptc therapeutics, inc.6
ptc therapeutics inc.2
Exclusivity

Patents and exclusivities

8
PatentProductCoversExpiry
11072614SEPHIENCEsepiapterinsubstanceApr 2038
11752154SEPHIENCEsepiapterinproductSept 2038
12213982SEPHIENCEsepiapterinuseSept 2038
12257252SEPHIENCEsepiapterinuseMar 2042
ProductExclusivityUntil
SEPHIENCESEPIAPTERINODE-542 Orphan drugJul 2032
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
EMFLAZAdeflazacorttablet, oral52856-501NDA
EMFLAZAdeflazacorttablet, oral52856-502NDA
EMFLAZAdeflazacorttablet, oral52856-503NDA
EMFLAZAdeflazacorttablet, oral52856-504NDA
EMFLAZAdeflazacortsuspension, oral52856-505NDA
KEBILIDIeladocagene exuparvovec-tneqsuspension, intracerebral52856-601BLA
Sephiencesepiapterinpowder, oral52856-201NDA
Sephiencesepiapterinpowder, oral52856-301NDA
Compare

Other companies listing deflazacort

Enquiry

Common questions

Is PTC Therapeutics, Inc. FDA approved?
PTC Therapeutics, Inc. holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does PTC Therapeutics, Inc. make?
8 products are listed under PTC Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet; powder; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.